Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #198933 on Biotech Values
DewDiligence
01/11/16 9:58 AM
#198938 RE: rwdm #198933
…Baxalta shareholders will receive $18.00 in cash and 0.1482 Shire ADS per Baxalta share. Based on Shire's closing ADS price on January 8, 2016, this implies a total current value of $45.57 per Baxalta share, representing an aggregate consideration of approximately $32 billion. …The value of the offer as of Shire's January 8, 2016 closing ADS price represents a premium of approximately 37.5% to Baxalta's unaffected share price on August 3, 2015, the day prior to the public announcement of Shire's initial offer for Baxalta. This will provide Baxalta shareholders with approximately 34% ownership in the combined company. Closing of the transaction is subject to approval by Baxalta and Shire shareholders… The parties expect the transaction to close mid-2016.